Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Innovative Phase I/II Statistical Design in Combination Chemotherapy That Combines Toxicity and Efficacy Parameters to Increase Study Efficiency: Bendamustine and Idarubicin in De Novo Adult AML
Blood (2011)
  • Jack M. Lionberger, Fred Hutchinson Cancer Research Center
  • Kathleen Shannon Dorcy, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Nathan Holm, Fred Hutchinson Cancer Research Center
  • Bart Lee Scott, Fred Hutchinson Cancer Research Center
  • J. Kyle Wathen, University of Texas Health Science Center at Houston
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 18, 2011
Citation Information
Jack M. Lionberger, Kathleen Shannon Dorcy, Carol Dean, Nathan Holm, et al.. "Innovative Phase I/II Statistical Design in Combination Chemotherapy That Combines Toxicity and Efficacy Parameters to Increase Study Efficiency: Bendamustine and Idarubicin in De Novo Adult AML" Blood Vol. 118 Iss. 21 (2011) p. 1552 - 1552
Available at: http://works.bepress.com/john-pagel/171/